Our recent study suggests that depletion of a specific group of gut bacteria that stimulate interleukin (IL)-17a-expressing T lymphocytes may be able to prevent AD progression in APP-transgenic mice [13]. The gene discussed is IL17A; the disease is Alzheimer disease.